These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 20406071

  • 1. Human bile as a rich source of biomarkers for hepatopancreatobiliary cancers.
    Gowda GA.
    Biomark Med; 2010 Apr; 4(2):299-314. PubMed ID: 20406071
    [Abstract] [Full Text] [Related]

  • 2. NMR spectroscopy for discovery and quantitation of biomarkers of disease in human bile.
    Gowda GA.
    Bioanalysis; 2011 Aug; 3(16):1877-90. PubMed ID: 21877897
    [Abstract] [Full Text] [Related]

  • 3. Combining nuclear magnetic resonance spectroscopy and mass spectrometry in biomarker discovery.
    Gowda GA, Ijare OB, Shanaiah N, Bezabeh T.
    Biomark Med; 2009 Jun; 3(3):307-22. PubMed ID: 20477478
    [Abstract] [Full Text] [Related]

  • 4. Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies.
    Brockmann J, Emparan C, Hernandez CA, Sulkowski U, Dietl KH, Menzel J, Wolters H, Glodny B, Senninger N.
    Anticancer Res; 2000 Jun; 20(6D):4941-7. PubMed ID: 11326643
    [Abstract] [Full Text] [Related]

  • 5. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer].
    Nakahara M, Fujisawa K.
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3010-9. PubMed ID: 2445292
    [Abstract] [Full Text] [Related]

  • 6. Proteomic analysis of human bile and potential applications for cancer diagnosis.
    Farina A, Dumonceau JM, Lescuyer P.
    Expert Rev Proteomics; 2009 Jun; 6(3):285-301. PubMed ID: 19489700
    [Abstract] [Full Text] [Related]

  • 7. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, Cavill R, Nicholson JK, Keun HC.
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [Abstract] [Full Text] [Related]

  • 8. Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer.
    Farina A, Dumonceau JM, Frossard JL, Hadengue A, Hochstrasser DF, Lescuyer P.
    J Proteome Res; 2009 Jan; 8(1):159-69. PubMed ID: 19055478
    [Abstract] [Full Text] [Related]

  • 9. Neoplasms of the hepatobiliary system: clinical presentation, molecular pathways and diagnostics.
    Chen CP, Haas-Kogan D.
    Expert Rev Mol Diagn; 2010 Oct; 10(7):883-95. PubMed ID: 20964609
    [Abstract] [Full Text] [Related]

  • 10. [Clinical characteristics and imaging diagnosis of early cancer in the hepatobiliary and pancreatic region].
    Mizumoto R, Ogura Y, Matsuda S.
    Gan No Rinsho; 1988 Aug; 34(10):1342-8. PubMed ID: 3050200
    [Abstract] [Full Text] [Related]

  • 11. Trypsinogen activation peptide (TAP) expression in gallbladder bile identifies bilio-pancreatic carcinoma.
    Brockmann JG, Hernandez CA, Emparan C, Wolters H, Haier J, Dietl KH, Senninger NJ.
    Anticancer Res; 2003 Aug; 23(2A):819-25. PubMed ID: 12820306
    [Abstract] [Full Text] [Related]

  • 12. Identification of urinary biomarkers useful for distinguishing a difference in mechanism of toxicity in rat model of cholestasis.
    Ishihara K, Katsutani N, Asai N, Inomata A, Uemura Y, Suganuma A, Sawada K, Yokoi T, Aoki T.
    Basic Clin Pharmacol Toxicol; 2009 Sep; 105(3):156-66. PubMed ID: 19486331
    [Abstract] [Full Text] [Related]

  • 13. Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies.
    Nakao A, Taniguchi K, Inoue S, Takeda S, Harada A, Nonami T, Watanabe K, Takagi H.
    Am J Gastroenterol; 1997 Jun; 92(6):1031-4. PubMed ID: 9177525
    [Abstract] [Full Text] [Related]

  • 14. Identification of bile biomarkers of biliary tract cancer through a liquid chromatography/mass spectrometry-based metabolomic method.
    Xu X, Cheng S, Ding C, Lv Z, Chen D, Wu J, Zheng S.
    Mol Med Rep; 2015 Mar; 11(3):2191-8. PubMed ID: 25405977
    [Abstract] [Full Text] [Related]

  • 15. Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders.
    Su WC, Shiesh SC, Liu HS, Chen CY, Chow NH, Lin XZ.
    Dig Dis Sci; 2001 Jul; 46(7):1387-92. PubMed ID: 11478488
    [Abstract] [Full Text] [Related]

  • 16. Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma.
    Koopmann J, Thuluvath PJ, Zahurak ML, Kristiansen TZ, Pandey A, Schulick R, Argani P, Hidalgo M, Iacobelli S, Goggins M, Maitra A.
    Cancer; 2004 Oct 01; 101(7):1609-15. PubMed ID: 15378479
    [Abstract] [Full Text] [Related]

  • 17. [Early diagnostic system of minute hepatocellular carcinoma, and neoplasms of biliary tract and pancreas].
    Okuda K, Tsuchiya Y, Saisho H.
    Nihon Rinsho; 1982 Oct 01; 40(1):146-50. PubMed ID: 6283199
    [No Abstract] [Full Text] [Related]

  • 18. The use of imaging in the diagnosis and staging of hepatobiliary malignancies.
    Miller G, Schwartz LH, D'Angelica M.
    Surg Oncol Clin N Am; 2007 Apr 01; 16(2):343-68. PubMed ID: 17560517
    [Abstract] [Full Text] [Related]

  • 19. Metabolomics of cancer.
    Serkova NJ, Glunde K.
    Methods Mol Biol; 2009 Apr 01; 520():273-95. PubMed ID: 19381962
    [Abstract] [Full Text] [Related]

  • 20. [Peroral endoscopical diagnosis for the early stage of cancer in bilio-pancreatic system].
    Murashima Y, Suga T, Koito K, Miyakawa H, Sato T.
    Rinsho Byori; 1990 Mar 01; 38(3):231-9. PubMed ID: 2190021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.